In androgen-dependent AR signaling, tumor cells can restore the AR signaling pathway by increasing the synthesis of circulating androgens (15, 16, 17) or by acquiring AR gene overexpression, amplification, and mutations that allow AR activation by attenuated levels of androgens following castration or ARPI (18–22). This evidence concerns the gene AR and neoplasm.